https://www.healthinsuranceandprotection.com/hidlogo.png

Health Insurance & Protection is part of the Business Intelligence Division of Informa PLC

Informa PLC | About us | Investor relations | Talent

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Skip to content
Health Insurance & Protection
NEWSLETTER SIGN UP Login
  • COVID-19
  • Business
    • All Business
    • Industry & Regulation
    • Appointments
  • Healthcare
    • All Healthcare
    • PMI
    • Cash Plans / Dental
    • Later Life Advice
    • Healthcare Trust
  • Protection
    • All Protection
    • Income Protection
    • Life / Critical Illness
    • Group Risk
  • International
  • Wellbeing
    • All Wellbeing
    • Mental Health
  • Reviews
  • Guides
  • Partners
  • Awards

APRIL International ups cover limits and makes changes to Singapore product

Early diagnosis in focus
David Sawers | 29th July 2020
 

International private medical insurance (iPMI) provider APRIL International Care has announced changes to its MyHEALTH Singapore iPMI product.

The annual cover limit for the Elite module clients for in-hospital care has been increased from S$4.5m to S$6m, while the out of area cover has also been increased from S$150,000 to S$250.000 for those holding the worldwide ex-US cover options.

New preventative screening benefits for adults mean the first $300 of any test is also now covered, whether the client has purchased inpatient or outpatient cover. Typical tests which can now be undertaken within APRIL International Care’s network of 1,200 local facilities include Pap smear testing, mammography and prostate screening.

Alistair Dickman, Regional Head of Business Development at APRIL International, said that the changes “reflect the fact that we are learning more and more how important it is to stay ahead of the game when it comes to diagnosis and treatment”.

He said: “For many conditions now, early diagnosis brings genuine benefits and faster recovery times. This new benefit opens up that possibility for many of our clients. In the long term too, it is in all our interests to diagnose and treat early, as it can cost far less, which in turn helps us to keep premiums lower.”



News, Opinion and Analysis

All the latest, straight to your inbox

Sign Up

We want to hear from you

To contact the editor

Click Here

Market Intelligence

Guides, reports, industry research and more

Download Here

Advertising

Online, print, events and more

Get in touch

  • About Us
  • Contact Us
  • Advertise
  • Terms of Use
  • Privacy Policy
  • Privacy Centre
The content of this website is © Informa Plc 5 Howick Place, London SW1P 1WG